Based on molecular markers, including estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2), breast cancer can be divided into three subtypes: hormone receptor (HR) positive, HER2 positive and triple-negative breast cancer (TNBC). The gene discussed is PGR; the disease is triple-negative breast carcinoma.